NanoTech Pharma Inc., headquartered in Hillsborough, NJ, USA, is a specialty pharmaceutical company dedicated to the development and commercialization of innovative drug delivery systems that power the next wave of precision nanomedicine. Our leadership team possesses advanced degrees with extensive professional knowledge and expertise in pharmaceutical product development from early-stage discovery to commercialization, particularly in the field of nanomedicine.
Our liposome platform is composed of four drug encapsulation methods: Lipo-Omni®, Hydro-Omni® Lipo-X® and Duo-Omni®. A specific drug encapsulation technology is selected based on the physicochemical properties of a compound of interest.
High drug encapsulation efficiency
Excellent product stability
Controlled drug release profile
Improved drug delivery specificity
Because our product candidates use already approved active pharmaceutical ingredients (APIs), we are eligible to utilize the streamlined 505(b)(2) regulatory pathway for approval in the United States and a similar pathway worldwide. Based on our proprietary technology platforms, we have assembled a diverse liposome product portfolio targeting the key areas of unmet medical needs (e.g., Oncology and cancer drug resistance, inflammation disorders, infectious disease and pain management).
The LNP formulation can be tailored for the encapsulation and delivery of different types of nucleic acids, including mRNA, siRNA, microRNA, self-amplifying mRNA, oligonucleotides, etc. AccuLNP® can be utilized to target a diverse range of therapeutic applications including protein therapy, mRNA vaccines, CAR-T cell therapy, gene editing and more.
Our proprietary nanocrystal platform is featured by high mass per volume drug loading, improved product stability, controlled drug release profile and reduced dose related toxicity. The therapeutic area we focus on are the following: mental disorders (e.g., schizophrenia), chronic inflammatory disorders, pain relief, infectious diseases, etc.
© 2024 NanoTech Pharm Inc. All rights reserved.